Clinical Trials Directory

Trials / Completed

CompletedNCT03495115

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
460 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is looking at a breast cancer screening technique, restriction spectrum imaging (RSI), as a possible alternative to the breast Magnetic Resonance Imaging (MRI) used by most healthcare professionals. The technique involved in this study is: -Restriction Spectrum Imaging (RSI)

Detailed description

The primary purpose of this research study is to measure RSI's ability to diagnose breast cancer in comparison to standard breast MRIs. RSI is a technique that has been shown to address the limitations of certain types of MRI exams used to make images of the prostate and brain. RSI is not a FDA-approved technique for screening, but is a type of advanced diffusion technique and diffusion weighted imaging is used as a part of the standard breast MRI. RSI has been shown to improve tumor detection in prostate and brain. For example, a recent pilot study in prostate showed that adding RSI improved the ability to find a certain stage of prostate cancer in comparison to an MRI without the use of the RSI technique. By comparing RSI's ability to diagnose breast cancer, future clinical testing can determine whether RSI is a more efficient way to screen for breast cancer.

Conditions

Interventions

TypeNameDescription
DEVICEMRIA MRI uses a strong magnet to produce detailed pictures of the inside of your body.
DEVICERSIRSI is a technique that aims to improve the pictures produced during a MRI exam.

Timeline

Start date
2018-04-18
Primary completion
2023-12-30
Completion
2023-12-30
First posted
2018-04-11
Last updated
2026-04-17
Results posted
2026-04-17

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03495115. Inclusion in this directory is not an endorsement.